Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

INnovative risk Stratification of heart faIlure throuGH explainable machine learning and compuTational modeling of Left Ventricle

Project description

Better cardiovascular risk prediction in high-risk groups

Heart failure affects millions of people globally, resulting in high healthcare costs and frequent hospitalisations. Current diagnostic tools often fail to predict adverse events. With the support of the Marie Skłodowska-Curie Actions programme, the INSIGHT-LV project will advance prediction by improving the evaluation of left ventricle function in high-risk groups, specifically those with hypertrophic cardiomyopathy (HCM) and COVID-19 patients. HCM lacks updated guidelines and effective predictors, while COVID-19 patients face cardiovascular risks. By using AI, machine learning, and advanced imaging techniques, the project will analyse multimodal data sets to create tools that optimise treatment strategies and personalise decision-making. The results will enhance risk stratification, setting new standards in cardiovascular diagnostics.

Objective

INSIGHT-LV aims to improve cardiovascular risk prediction by enhancing the evaluation of left ventricle function using multimodal methods. Heart failure (HF) affects over 26 million people globally, with high healthcare costs and hospitalization rates. Current diagnostic tools often fail to accurately predict adverse events, highlighting the need for more effective risk prediction models that integrate diverse clinical data.

INSIGHT-LV focuses on two high-risk HF groups: hypertrophic cardiomyopathy (HCM) and COVID-19 patients. HCM, a major cause of sudden cardiac death in young people, lacks updated guidelines and relies on limited predictors. COVID-19 patients show significant cardiovascular risks, creating an urgent need for better risk stratification tools. These two groups represent a substantial part of the HF population requiring improved stratification.

The project will provide clinicians with tools to deliver optimized, cost-effective treatment strategies. By characterizing and stratifying HCM and COVID-19 patients, INSIGHT-LV aims to personalize decision-making and advance disease understanding. Using computational modeling, AI, machine learning, and advanced signal and image processing, the project will integrate multimodal datasets, including ECGs, MRIs, genetic tests, and echocardiography, ensuring robust clinical solutions.

INSIGHT-LV will test AI models on real-world data to validate improvements in predicting risks such as sudden cardiac death and arrhythmias. This work will set new standards for cardiovascular diagnostics, delivering scientific, societal, and economic benefits.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2024-PF-01

See all projects funded under this call

Coordinator

POLITECNICO DI MILANO
Net EU contribution
€ 193 643,28
Address
PIAZZA LEONARDO DA VINCI 32
20133 Milano
Italy
Region
Nord-Ovest Lombardia Milano
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data